Charles Jacques

Charles Jacques serves as the Chief Financial Officer at both Cellistic and Ncardia, bringing expertise in financial leadership within the cell therapy and human iPSC technology sectors. In addition to these roles, Jacques holds a position as a Board Member at Rhizome Network, a Contract Research Organization in agriculture, and operates CJA Consulting SRL, providing financial consulting services. Previous experience includes a directorial role at EKKOFIN, finance transformation consulting at Imcyse SA, and finance leadership at Catalent Pharma Solutions and MaSTherCell, where Jacques significantly contributed to financial planning, strategy, and compliance in fast-paced biopharmaceutical environments. Academic credentials were earned from Université de Namur.